Showing results 1 to 20 of 44
next >
| Issue Date | Title | Author(s) | Type | М-cat. |
| 2012 | Adiponectin, non-esterified fatty acids and antiphospholipid antibodies in type II diabetes mellitus | Becarević, Mirjana   ; Seferović, Jelena; Ignjatović, Svetlana ; Singh, Sandra; Majkić-Singh, Nada | Article | |
| 2019 | Adiponectin: a therapeutic target in the antiphospholipid syndrome? (✓) | Becarević, Mirjana ; Nikolić, Bozana ; Ignjatović, Svetlana | Article | |
| 2018 | Anti-annexin A5 antibodies and 25-hydroxy-cholecalciferol in female patients with primary antiphospholipid syndrome (✓) | Becarević, Mirjana ; Sarić, Marija ; Stojanović, Ljudmila ; Mirković, Duško ; Dopsaj, Violeta ; Ignjatović, Svetlana | Article | |
| 2005 | Anti-oxLDL antibodies - marker for arterial thromboses in antiphospholipid syndrome (✓) | Bećarević, Mirjana ; Andrejević, Slađana ; Bonači-Nikolić, Branka ; Obradović, Ivana; Miljić, Predrag ; Majkić-Singh, Nada T. | Article | |
| 2006 | Anti-oxLDL antibodies, homocysteine and apolipoproteins in primary antiphospholipid syndrome (✓) | Bećarević, Mirjana ; Mirković, Duško ; Miljić, Predrag ; Andrejević, Slađana ; Obradović, Ivana; Bonači-Nikolić, Branka ; Majkić-Singh, Nada ; Majkić-Sing, Nada | Article | |
| 2017 | Antibodies Against Complement Components: Relevance for the Antiphospholipid Syndrome—Biomarkers of the Disease and Biopharmaceuticals | Bećarević, Mirjana | Article | |
| 2017 | Antiphospholipid Antibodies and Renal Impairment Parameters in Diabetic Nephropathy: Preliminary Data (✓) | Becarević, Mirjana ; Cabarkapa, Velibor ; Djerić, Mirjana ; Ignjatović, Svetlana | Article | |
| 2022 | Antiphospholipid antibodies in healthy serbian middle-aged subjects: preliminary data (✓) | Bećarević, Mirjana ; Jovičić, Snežana ; Ignjatović, Svetlana ; Mirković, Duško | Article | |
| 2021 | Antiphospholipid antibodies in patients with Graves’ orbitopathy: preliminary data (✓) | Bećarević, Mirjana ; Sarić-Matutinović, Marija ; Žarković, Miloš ; Nedeljković-Beleslin, Biljana ; Ćirić, Jasmina ; Ignjatović, Svetlana | Article | |
| 2013 | Apoptosis, annexin a5 and anti-Annexin a5 antibodies in the antiphospholipid syndrome | Becarević, Mirjana ; Ignjatović, Svetlana ; Majkić-Singh, Nada | Article | |
| 2011 | Association of tnf-alpha and anticardiolipin antibodies in type ii diabetes mellitus (✓) | Becarević, Mirjana ; Seferović, Jelena; Ignjatović, Svetlana ; Majkić-Singh, Nada | Conference Paper | |
| 2015 | Biofarmaceutici - monoklonska antitela u dijagnostici i terapiji autoimunih inflamatornih oboljenja | Bećarević, Mirjana | Monograph | |
| 2012 | Biofarmaceutske karakteristike preparata u tretmanu antifosfolipidnog sindroma | Bećarević, Mirjana | Monograph | |
| 2022 | Biofarmacija (✓) | Bećarević, Mirjana | Text book | |
| 2022 | Biofarmacija | Bećarević, Mirjana | Text book | |
| 2023 | Biofarmacija 2 (✓) | Bećarević, Mirjana | Text book | |
| 2012 | Deterioration of Thromboses in Primary Antiphospholipid Syndrome: TNF-alpha and Anti-Annexin A5 Antibodies | Becarević, Mirjana ; Ignjatović, Svetlana ; Majkić-Singh, Nada | Article | |
| 2017 | Detrimental roles of TNF-alpha in the antiphospholipid syndrome and de novo synthesis of antiphospholipid antibodies induced by biopharmaceuticals against TNF-alpha | Bećarević, Mirjana | Article | |
| 2016 | Double positivity of the IgG isotype of both anticardiolipin and anti-beta 2gpI antibodies is associated with the highest number of vascular impairment parameters in patients with primary antiphospholipid syndrome: preliminary data | Becarević, Mirjana ; Mirković, Duško ; Ignjatović, Svetlana | Article | |
| 2018 | Exposure to potential drug-antimicrobial agent interactions in primary health care (✓) | Nikolić, Božana ; Popović, Jovan ; Bećarević, Mirjana ; Rakić, Dušica | Article | |